eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
1/2011
vol. 28
 
Share:
Send email
Share:
abstract:

Original paper
Granuloma faciale – analysis of 5 cases

Igor Michajłowski
,
Michał Sobjanek
,
Dorota Kozicka
,
Magdalena Dobosz
,
Adam Włodarkiewicz

Post Dermatol Alergol 2011; XXVIII, 1: 36–40
Online publish date: 2011/03/07
View full text Get citation
 
Introduction : Granuloma faciale (GF) is an uncommon inflammatory dermatosis. The treatment of GF remains a challenge considering the unclear aetiopathogenesis. Various therapeutic methods have been described.

Aim : To analyse the clinical picture and treatment results in a group of patients with GF.

Material and methods : Five adults with GF were analysed and treated. Diagnosis was confirmed by histological examination. Patients were treated with surgery, cryosurgery, topically with corticosteroids and tacrolimus. The follow-up period varied from 5 to 15 months.

Results : Complete resolution was observed in 3 cases, partial remission was noted in 1 case. In 1 case the treatment was unsuccessful.

Conclusions : The treatment of GF remains a challenge. It is difficult to determine the most effective therapy. Topical tacrolimus and cryosurgery seem to be the first line treatment.
keywords:

granuloma faciale, treatment, tacrolimus, calcineurin inhibitors
FEATURED PRODUCTS
BOOKS
• Atopowe Zapalenie Skóry • Choroby alergiczne w praktyce lekarza rodzinnego • Alergologia – kompendium
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.